SCHEMBL14101568

SCHEMBL14101568

c1ccc(-c2cc(-c3ccc4sc5ccccc5c4c3)c3ccc4c(-c5ccccc5)cc(-c5ccc6sc7ccccc7c6c5)c5ccc2c3c45)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 1/20 0.45
MAPT P10636 4/20 0.42
ALDH1A1 P00352 3/20 0.42
HPGD P15428 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
RAB9A P51151 1/20 0.42
F9 P00740 1/20 0.40
ALOX5 P09917 1/20 0.40
PIM3 Q86V86 1/20 0.40
CYP1A2 P05177 1/20 0.39
PTPN7 P35236 1/20 0.38
DUSP3 P51452 1/20 0.38
PTPN12 Q05209 1/20 0.38
PTPN22 Q9Y2R2 1/20 0.38
TNKS O95271 1/20 0.37
TNKS2 Q9H2K2 1/20 0.37
POLB P06746 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CHEK1 O14757 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14101439 0.95 F9 (0.40) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14101569 0.92 MAPT (0.47) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL18907472 0.87 GPR3 (0.48) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14101437 0.86 F9 (0.38) MAPTALDH1A1HPGDF9ALOX5
SCHEMBL14101487 0.86 GPR3 (0.41) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL14101524 0.86 GPR3 (0.41) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL21346370 0.86 ALDH1A1 (0.35) MAPTALDH1A1HPGDSMN1; SMN2RAB9A
SCHEMBL13408816 0.86 GPR3 (0.44) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL18907463 0.85 GPR3 (0.47) GPR3MAPTALDH1A1HPGDSMN1; SMN2
SCHEMBL21190409 0.84 CYP1A1 (0.37) GPR3MAPTALDH1A1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME IDEMITSU KOSAN CO., LTD. (JP) 2008-07-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080166594-A1 BENZOTHIOPHENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE MAKING USE OF THE SAME CYBA, BPNT1, TYR GPR3 4579/4885MAPT 226/4885ALDH1A1 70/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.